Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units
Imprimis Pharmaceuticals, Inc. | December 19, 2016
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of Directors and senior management, including the CEO, CFO, and Senior Director of Corporate Development, to raise gross proceeds of approximately $9.8 million in a private placement of Units…